Neuronetics, Inc. (STIM) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 76.20M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 76.20M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 76.20M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 76.20M | (m) | (m) |
| 2026-03-31 | 69.59M | (m) | (m) |
| 2025-12-31 | 69.28M | (m) | (m) |
| 2025-09-30 | 68.49M | (m) | (m) |
| 2025-06-30 | 66.12M | (m) | (m) |
| 2025-03-31 | 65.82M | (m) | (m) |
| 2024-09-30 | 30.35M | (m) | (m) |
| 2024-06-30 | 30.30M | (m) | (m) |
| 2024-03-31 | 30.00M | (m) | (m) |
| 2023-12-31 | 29.76M | (m) | (m) |
| 2023-09-30 | 28.93M | (m) | (m) |
| 2023-06-30 | 28.87M | (m) | (m) |
| 2023-03-31 | 28.50M | (m) | (m) |
| 2022-12-31 | 28.36M | (m) | (m) |
| 2022-09-30 | 27.22M | (m) | (m) |
| 2022-06-30 | 27.02M | (m) | (m) |
| 2022-03-31 | 26.77M | (m) | (m) |
| 2021-12-31 | 26.63M | (m) | (m) |
| 2021-09-30 | 26.37M | (m) | (m) |
| 2021-06-30 | 26.32M | (m) | (m) |
| 2021-03-31 | 25.76M | (m) | (m) |
| 2020-12-31 | 25.41M | (m) | (m) |
| 2020-09-30 | 18.98M | (m) | (m) |
| 2020-06-30 | 18.86M | (m) | (m) |
| 2020-03-31 | 18.73M | (m) | (m) |
| 2019-12-31 | 18.67M | (m) | (m) |
| 2019-09-30 | 18.63M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |